Attention: We have moved. Merck Millipore products are no longer available for purchase on MerckMillipore.com.Learn More

203890 CRAC Channel Inhibitor, BTP2 - CAS 223499-30-7 - Calbiochem

203890
Purchase on Sigma-Aldrich

Descripción

Replacement Information

Tabla espec. clave

Empirical FormulaCAS #
C₁₅H₉F₆N₅OS 223499-30-7

Products

Número de referenciaEmbalaje Cant./Env.
203890-5MG Ampolla de plást. 5 mg
Description
OverviewA cell-permeable pyrazole that acts as a more potent blocker of Stim1 and Orai1-coupled CRAC (Ca2+ release-activated Ca2+) channel-mediated SOCE (store-operated Ca2+ entry) in RBL-2H3 cells (IC50 = 590 nM by Fura-2; peak current density pA/pF = -1.13 and -7.50, respectively, with or without 3 µM BTP2/Pyr2 by whole cell clamp) than the transient receptor potential cation channel TRPC3-mediated ROCE (receptor-operated Ca2+ entry) inTRPC3-expressing HEK293 cells (IC50 = 4.21 µM by Fura-2; pA/pF = -1.54 and -18.50, respectively, with or without 3 µM BTP2/Pyr2). A great complement to Pyr 3 (Cat. No. 648490), Pyr6, and Pyr10 in Ca2+ signaling studies.
Catalogue Number203890
Brand Family Calbiochem®
Synonyms[N-{4-[3,5-bis(Trifluoromethyl)-1H-pyrazol-1-yl]phenyl}-4-methyl-1,2,3-thiadiazole-5-carboxamide], Pyr2, TPRC3 Channel Inhibitor II
References
ReferencesSchleifier, H., et al. 2012. Br J Pharmacol In Press
Yonetoku, Y., et al. 2006. Bioorg. Med. Chem. 14, 5370.
Yonetoku, Y., et al. 2006. Bioorg. Med. Chem. 14, 4750.
Zitt, C., et al. 2004. J. Biol. Chem. 279, 12927.
Trevillyan, J.M., et al. 2001. J. Biol. Chem. 276, 48118.
Djuric, S.W., et al. 2000. J. Med. Chem. 43, 2975.
Product Information
CAS number223499-30-7
ATP CompetitiveN
FormSolid
Hill FormulaC₁₅H₉F₆N₅OS
Chemical formulaC₁₅H₉F₆N₅OS
ReversibleN
Structure formula ImageStructure formula Image
Applications
ApplicationCRAC Channel Inhibitor, BTP2, CAS 223499-30-7, is a cell-permeable, potent blocker of Stim1 and Orai1-coupled Ca2+ release-activated Ca2+ channel-mediated SOCE in RBL-2H3 cells (IC50 = 590 nM).
Biological Information
Primary TargetCRAC Channel
Primary Target IC<sub>50</sub>590 nM by Fura-2
Purity≥95% by HPLC
Physicochemical Information
Cell permeableY
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Storage and Shipping Information
Ship Code Ambient Temperature Only
Toxicity Standard Handling
Storage +2°C to +8°C
Protect from Light Protect from light
Do not freeze Ok to freeze
Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C.
Packaging Information
Packaged under inert gas Packaged under inert gas
Transport Information
Supplemental Information
Specifications

Documentation

CRAC Channel Inhibitor, BTP2 - CAS 223499-30-7 - Calbiochem Ficha datos de seguridad (MSDS)

Título

Ficha técnica de seguridad del material (MSDS) 

CRAC Channel Inhibitor, BTP2 - CAS 223499-30-7 - Calbiochem Certificados de análisis

CargoNúmero de lote
203890

Referencias bibliográficas

Visión general referencias
Schleifier, H., et al. 2012. Br J Pharmacol In Press
Yonetoku, Y., et al. 2006. Bioorg. Med. Chem. 14, 5370.
Yonetoku, Y., et al. 2006. Bioorg. Med. Chem. 14, 4750.
Zitt, C., et al. 2004. J. Biol. Chem. 279, 12927.
Trevillyan, J.M., et al. 2001. J. Biol. Chem. 276, 48118.
Djuric, S.W., et al. 2000. J. Med. Chem. 43, 2975.
Ficha técnica

Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

Revision21-June-2013 JSW
Synonyms[N-{4-[3,5-bis(Trifluoromethyl)-1H-pyrazol-1-yl]phenyl}-4-methyl-1,2,3-thiadiazole-5-carboxamide], Pyr2, TPRC3 Channel Inhibitor II
DescriptionA cell-permeable pyrazole that acts as a more potent blocker of Stim1 and Orai1-coupled CRAC (Ca2+ release-activated Ca2+) channel-mediated SOCE (store-operated Ca2+ entry) in RBL-2H3 cells (IC50 = 590 nM by Fura-2; peak current density pA/pF = -1.13 and -7.50, respectively, with or without 3 µM BTP2/Pyr2 by whole cell clamp) than the transient receptor potential cation channel TRPC3-mediated ROCE (receptor-operated Ca2+ entry) inTRPC3-expressing HEK293 cells (IC50 = 4.21 µM by Fura-2; pA/pF = -1.54 and -18.50, respectively, with or without 3 µM BTP2/Pyr2). A great complement to Pyr 3 (Cat. No. 648490), Pyr6, and Pyr10 in Ca2+ signaling studies.
FormSolid
Intert gas (Yes/No) Packaged under inert gas
CAS number223499-30-7
Chemical formulaC₁₅H₉F₆N₅OS
Structure formulaStructure formula
Purity≥95% by HPLC
SolubilityDMSO (5 mg/ml)
Storage +2°C to +8°C
Protect from light
Do Not Freeze Ok to freeze
Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C.
Toxicity Standard Handling
ReferencesSchleifier, H., et al. 2012. Br J Pharmacol In Press
Yonetoku, Y., et al. 2006. Bioorg. Med. Chem. 14, 5370.
Yonetoku, Y., et al. 2006. Bioorg. Med. Chem. 14, 4750.
Zitt, C., et al. 2004. J. Biol. Chem. 279, 12927.
Trevillyan, J.M., et al. 2001. J. Biol. Chem. 276, 48118.
Djuric, S.W., et al. 2000. J. Med. Chem. 43, 2975.